This website is managed by Ultima Markets’ international entities, and it’s important to emphasise that they are not subject to regulation by the FCA in the UK. Therefore, you must understand that you will not have the FCA’s protection when investing through this website – for example:
You will not be guaranteed Negative Balance Protection
You will not be protected by FCA’s leverage restrictions
You will not have the right to settle disputes via the Financial Ombudsman Service (FOS)
You will not be protected by Financial Services Compensation Scheme (FSCS)
Any monies deposited will not be afforded the protection required under the FCA Client Assets Sourcebook. The level of protection for your funds will be determined by the regulations of the relevant local regulator.
Note: UK clients are kindly invited to visit https://www.ultima-markets.co.uk/. Ultima Markets UK expects to begin onboarding UK clients in accordance with FCA regulatory requirements in 2026.
If you would like to proceed and visit this website, you acknowledge and confirm the following:
1.The website is owned by Ultima Markets’ international entities and not by Ultima Markets UK Ltd, which is regulated by the FCA.
2.Ultima Markets Limited, or any of the Ultima Markets international entities, are neither based in the UK nor licensed by the FCA.
3.You are accessing the website at your own initiative and have not been solicited by Ultima Markets Limited in any way.
4.Investing through this website does not grant you the protections provided by the FCA.
5.Should you choose to invest through this website or with any of the international Ultima Markets entities, you will be subject to the rules and regulations of the relevant international regulatory authorities, not the FCA.
Ultima Markets wants to make it clear that we are duly licensed and authorised to offer the services and financial derivative products listed on our website. Individuals accessing this website and registering a trading account do so entirely of their own volition and without prior solicitation.
By confirming your decision to proceed with entering the website, you hereby affirm that this decision was solely initiated by you, and no solicitation has been made by any Ultima Markets entity.
Ultima Markets does not have an establishment in Singapore and does not operate from Singapore.
Ultima Markets does not provide products or services to citizens or residents of Singapore, and account applications from Singapore citizens or residents will not be accepted.
If you are a citizen or resident of Singapore, please do not open an account or use Ultima Markets’ products or services.
By selecting “Acknowledge and Continue Browsing”, you confirm that you are accessing this website on your own initiative and that your access is not the result of any direct marketing, targeted advertising, solicitation, or promotional activity by Ultima Markets.
Nothing on this website constitutes an offer, solicitation, or promotion of products or services in any jurisdiction where such activity is prohibited. You are responsible for ensuring that your access to and use of this website complies with applicable local laws and regulations.
Read the Gevo stock forecast for 2027 and beyond, explore analyst price targets and key growth drivers, and see whether GEVO could expand through 2030.
The Gevo stock forecast has become a lot more interesting after a record quarter for the renewable fuels company. Gevo (NASDAQ: GEVO) reported $83 million in third-quarter 2026 revenue and turned a profit, helped by its ethanol operations and carbon credit business.
Still, the outlook is hard to price. Wall Street targets run from $1.20 to $14, which shows how differently analysts see Gevo’s future earnings and its sustainable aviation fuel (SAF) opportunity. The big test is whether the company can stay profitable without leaning on one-off credit sales.
Gevo Stock Price Forecast
Metric
Latest figure
GEVO reference share price
$1.64
Average analyst 12-month target
$5.11
Median analyst 12-month target
$2.63
Lowest / highest analyst target
$1.20 / $14.00
2027 estimated revenue
$213.33 million
2027 estimated adjusted EPS
$0.06
Company’s 2027 adjusted EBITDA outlook
More than $70 million
The share price is the latest quote on 18 November 2026. Targets generally cover about 12 months from issue, not fixed year-end 2027 prices. Adjusted EPS and EBITDA are non-GAAP measures. Source: Stock Analysis.
What Does Gevo Do?
Gevo develops renewable fuels and runs businesses tied to low-carbon ethanol, renewable natural gas and carbon capture. Its longer-term goal is making SAF from ethanol, which is designed to cut aviation’s lifecycle emissions compared with conventional jet fuel, although the saving depends on how it’s produced.
So investors are really following two stories: existing operations that need to generate reliable cash flow, and development projects that need to prove they can be commercially viable.
A Strong Quarter With a Catch
Gevo’s third-quarter 2026 results were a record:
Metric
Q3 2025
Q3 2026
Revenue
$43 million
$83 million
Gross profit
$13 million
$48 million
Net income attributable to Gevo
Loss of $8 million
Profit of $23 million
Adjusted EBITDA
$7 million
$44 million
Operating cash flow
n/a
$41 million
Revenue rose about 93% year on year, diluted GAAP earnings came to $0.09 per share, and Gevo ended September with about $68 million in cash and cash equivalents.
Here’s the catch. The quarter included $29.4 million of revenue from Canadian Clean Fuel Regulation credits, and around $20 million of that was a non-recurring adjustment for credits built up before regulatory approval. The quarter still matters, because Gevo proved it can monetise credits and improve cash flow. But it’s wise to be cautious about treating the full $83 million as a repeatable run rate.
Gevo Stock Forecast for 2027
Forecasts point to better underlying earnings, although revenue growth slows sharply from 2026’s headline figures.
What Do Analysts Expect?
Forecast
2026 estimate
2027 estimate
Revenue
$208.28 million
$213.33 million
Revenue growth
29.7%
2.4%
Adjusted EPS
-$0.02
$0.06
Source: Stock Analysis estimates from S&P Global Market Intelligence. EPS figures are adjusted, not GAAP.
The small revenue rise is partly because the 2026 comparison includes the benefit of banked credits, so margins and cash flow matter more than the top line. Management expects more than $70 million of adjusted EBITDA in 2027, compared with more than $90 million for 2026. Those are company outlooks, not analyst consensus, and because the 2026 figure includes the non-recurring credit revenue, the lower 2027 number doesn’t automatically mean a weaker business.
What Could Support GEVO in 2027?
Two things stand out.
First, an upgrade to Gevo’s North Dakota ethanol plant is nearing completion, lifting nameplate capacity to about 75 million gallons a year, with completion targeted by the end of 2026.
Second, Gevo expects its contracted sales of Section 45Z clean fuel production credits, which it said amounted to $70 million for 2026, to grow in 2027 as production rises. Credit revenue depends on production, eligibility and policy, so it isn’t guaranteed.
If the plant delivers and credits hold up, investors could gain confidence in Gevo’s ability to fund its growth. If costs rise or credit values disappoint, the market may value the longer-term projects less.
GEVO Analyst Price Targets: Bear, Base and Bull
Four analysts cover GEVO in the dataset:
Analyst
Firm
Rating
Target
Date
Jeff Grampp
Northland Securities
Buy
$3.25
11 November 2026
Amit Dayal
H.C. Wainwright
Buy
$14.00
11 November 2026
Lloyd Byrne
Jefferies
Hold
$1.70
9 September 2026
Manav Gupta
UBS
Hold
$2.00
22 May 2026
Northland’s target implies a gain of about 98.2% from $1.64, Jefferies’ just 3.7% and UBS’s 22.0%, although UBS’s is older than the November updates.
We can use those targets as reference points for three outcomes. These scenarios are our interpretation, not the analysts’ own bear, base and bull cases:
Scenario
Reference target
Change from $1.64
What investors may be pricing in
Bear
$1.20 (lowest target)
-26.8%
Weaker credit economics, project delays or financing worries
Base
$2.63 (median target)
+60.4%
Improved operations and moderate confidence in growth plans
Bull
$14.00 (H.C. Wainwright)
+753.7%
A much stronger revaluation as earnings and projects develop
The $5.11 average target is about 211.6% above $1.64, but the $14 target is a big outlier that pulls the average well above the $2.63 median. With only four analysts, one change can swing the average.
Two caveats on the data. The individual targets don’t reconcile neatly with the provider’s consensus low and average, because they come from different feeds, so treat the figures as indicative and check for updates. I also couldn’t confirm a current GEVO-specific target from Morgan Stanley or Goldman Sachs, so their names shouldn’t be attached to any forecast.
Gevo Stock Forecast for 2030 and Beyond
A reliable analyst-backed 2030 target wasn’t available, and stretching 12-month targets out to 2030 would suggest false precision. The longer-term view is better judged by milestones:
2027 to 2028, expansion and financing: A proposed expansion would roughly double ethanol production and carbon capture, with operations expected in 2028 if it goes to plan. Management is still working on the financing, so watch the final cost, Gevo’s ownership stake, project debt and any new share issuance. More production could lift earnings, but the benefit per share depends on how it’s funded.
2028 to 2030, Project Northstar: Also called ATJ-30, this proposed alcohol-to-jet project in North Dakota is designed to produce about 30 million gallons of hydrocarbons a year, mostly SAF. It’s still in development, with Gevo seeking enough commercial offtake agreements and financing before a final investment decision. A signed offtake agreement alone wouldn’t guarantee construction or profitability.
Beyond 2030, a bigger market: The International Air Transport Association estimated global SAF production at about 2.4 million tonnes in 2026, only 0.8% of aviation fuel consumption. SAF also remains roughly two to three times more expensive than conventional jet fuel. A growing market doesn’t automatically mean a higher share price, because Gevo still has to build at competitive cost, secure customers and earn enough after financing.
What Are the Biggest Risks for GEVO Stock?
Reliance on credits and incentives: Changes in regulations, eligibility, credit prices or demand could hit future margins.
Financing and dilution: New facilities need big investment. Issuing shares could dilute existing investors, and debt brings interest and repayment obligations.
Execution and commodity costs: Higher corn, energy or construction costs could cut project returns, and delays could push back revenue.
Wide analyst disagreement: The gap between $1.20 and $14 shows how uncertain valuation is. Large projected upside isn’t the same as a high chance of achieving it.
Is GEVO Stock a Buy?
Gevo’s recent results give investors more evidence of a working business than a story built only on future SAF production. Positive third-quarter earnings, better cash flow and the 2027 adjusted EBITDA outlook are all encouraging.
Stock Analysis lists a Buy consensus, with two strong buys and two holds. That’s a positive overall view, but not a unanimous strong buy, and the wide spread in targets makes the median worth watching alongside the average.
For anyone weighing up the Gevo stock forecast, the key question is whether the company can sustain earnings once one-off credit revenue fades, and finance its expansion on attractive terms. GEVO offers potential exposure to a growing low-carbon fuels market, but its valuation stays highly sensitive to policy, project execution and funding.
FAQs
What is the Gevo stock forecast for 2027?
The average analyst 12-month target is $5.11, with a median of $2.63. These are rolling targets, not guaranteed year-end 2027 forecasts.
Can GEVO stock reach $3?
It’s possible but not guaranteed. Northland Securities has a $3.25 target, while other analysts’ targets are lower.
What is the GEVO stock forecast for 2030?
A verified Wall Street price target for 2030 wasn’t available. The outlook depends on project financing, SAF development and future profitability.
Is GEVO a strong buy?
Stock Analysis lists an overall Buy consensus, based on two strong buys and two holds. Weigh the potential upside against financing and execution risks.
Share Now
Disclaimer:This content is provided for informational purposes only and does not constitute, and should not be construed as, financial, investment, or other professional advice. No statement or opinion contained herein should be considered a recommendation by Ultima Markets or the author regarding any specific investment product, strategy, or transaction. Readers are advised not to rely solely on this material when making investment decisions and should seek independent advice where appropriate.
Thank you for visiting the Ultima Markets website. Please note that this website is intended for individuals residing in jurisdictions where access is permitted by law. Ultima and its affiliated entities do not operate in your home jurisdiction.
By clicking ‘Acknowledge’, you confirm that you are entering this website solely on your own initiative and not as a result of any specific marketing outreach. You wish to obtain information from this website based on reverse solicitation principles, in accordance with the applicable laws of your home jurisdiction.